- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Cardea Bio Inc.
Headquarters: San Diego, CA, United States
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | May 9, 2024
Management Tracks
Meyrick succeeding CMO Harris at radiopharma ITM
Plus: ALX hires Dillon and updates from Obsidian, YS and more
BioCentury | Jun 16, 2023
Discovery & Translation
Cardea’s COVID biosensor; plus gut microbes in Alzheimer’s risk and more
BioCentury’s roundup of translational news
BioCentury | Dec 16, 2022
Management Tracks
Resilience hires Rubius, Novartis vet Fisk as CTO
Plus: Seely named president and CEO at Lyell, and updates from Codagenix, Vigil, Hookipa and Cybrexa
BioCentury | Mar 1, 2022
Emerging Company Profile
Cardea Bio: high-speed biosensing using graphene
San Diego company’s technology allows molecular binding events to be monitored electrically, in real time
BioCentury | Jan 14, 2021
Deals
Jan. 13 Quick Takes: Takeda, KSQ enter immunotherapy deal; plus Taysha, Cardea, Esperion-Serometrix, Paion-La Jolla and more
KSQ Therapeutics Inc. granted Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) exclusive, global rights to develop, manufacture and commercialize cell and non-cell therapies that modulate targets
Items per page:
1 - 5 of 5